Lymphoma Physician-Scientist Oliver Press, MD, PhD, Dies at 65

Oliver Press, MD, PhD, a blood cancer physician-scientist who made foundational contributions to the development of targeted cancer therapies, died Friday of complications from glioma. He was 65 years old.

Dr. Press was the David and Patricia Giuliani/Oliver Press Endowed Chair for Cancer Research at Fred Hutchinson Cancer Research Center; a member of the Clinical Research Division at Fred Hutch; and Professor of Medicine, Adjunct Professor of Bioengineering, and Co-Director of the Center for Intracellular Delivery of Biologics and Nanotechnology Training Program at the University of Washington.

To read more about Dr. Press’ life and the impact of his research, read Fred Hutch’s tribute to him here.

The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.